Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

CompletedOBSERVATIONAL
Enrollment

668

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Heparin Induced Thrombocytopenia
Trial Locations (21)

10065

Cornell University, New York

15213

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21201

University of Maryland Greenebaum Cancer Center, Baltimore

21205

Johns Hopkins, Baltimore

27599

University of North Carolina, Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

44106

Case Western Reserve University School of Medicine, Cleveland

44195

Cleveland Clinic, Cleveland

52242

University of Iowa, Iowa City

53201

Froedtert, Milwaukee

53215

St. Luke's Medical Center, Milwaukee

53792

University of Wisconsin Comprehensive Cancer Center, Madison

54601

Gunderson Clinic, La Crosse

55455

University of Minnesota, Minneapolis

70112

Tulane University, New Orleans

98104

Fred Hutchinson Cancer Research Center, Seattle

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

Children's Hospital, Boston, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Carelon Research

OTHER